NCT05326841View on ClinicalTrials.gov

Effect of Cholecalciferol Supplementation on Disease Activity and Quality of Life of Systemic Lupus Erythematosus Patients .

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 3, 2021

Primary Completion Date

January 11, 2022

Study Completion Date

January 11, 2022

Conditions
Lupus Erythematosus, SystemicCholecalciferol SupplementationDisease ActivityQuality of Life
Interventions
DRUG

Vitamin D3

cholecalciferol tablet, the dose is 5000 international unit /day for 12 weeks

Trial Locations (1)

10430

Rscm Divisi Alergi Imunologi, Jakarta Pusat

All Listed Sponsors
lead

Dr Cipto Mangunkusumo General Hospital

OTHER

NCT05326841 - Effect of Cholecalciferol Supplementation on Disease Activity and Quality of Life of Systemic Lupus Erythematosus Patients . | Biotech Hunter | Biotech Hunter